Our mission at NAVERIS is to deliver innovations in technology with the potential to transform cancer detection, drug development, and clinical trials. Early detection of malignant cancers is critical to ensuring that tumors can be effectively treated with a favorable prognosis for patients. To this end, we are developing several related technologies with the potential to offer highly sensitive and specific cancer detection through blood analysis. Our flagship technology is a liquid biopsy blood test that analyzes tumor DNA in the circulation to detect specific subtypes of cancer. In clinical studies, this test has established its ability to detect cancers early – in many cases months before patients would be symptomatic given current clinical practice.
View Top Employees from NAVERISWebsite | http://www.navdx.com |
Employees | 71 (57 on RocketReach) |
Founded | 2017 |
Address | 22 Strathmore Rd, Natick, Massachusetts 01760, US |
Phone | (833) 628-3747 |
Technologies |
JavaScript,
HTML,
PHP
+28 more
(view full list)
|
Industry | Biotechnology Research, Biotechnology, Science and Engineering, Health Care |
Looking for a particular NAVERIS employee's phone or email?
James McNally is the CEO of NAVERIS.
57 people are employed at NAVERIS.
NAVERIS is based in Natick, Massachusetts.